SSRIs in pregnancy linked to autism

PRENATAL exposure to SSRIs may modestly increase the risk of developing an autism spectrum disorder (ASD), preliminary research findings suggest.

Researchers found a twofold increased risk of ASD associated with SSRI treatment in the mother during the year before delivery and a threefold increased risk associated with treatment during the first trimester in a population-based case control study in California.

Prenatal exposure to SSRIs was reported for 20 (6.7%) of 298 case children with ASD and 50 (3.3%) of 1507 control children.

The findings from the study – the first to directly examine